Hong‐Yu Tseng

698 total citations · 1 hit paper
7 papers, 510 citations indexed

About

Hong‐Yu Tseng is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Hong‐Yu Tseng has authored 7 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Hong‐Yu Tseng's work include Immune cells in cancer (4 papers), Seaweed-derived Bioactive Compounds (2 papers) and Endometriosis Research and Treatment (2 papers). Hong‐Yu Tseng is often cited by papers focused on Immune cells in cancer (4 papers), Seaweed-derived Bioactive Compounds (2 papers) and Endometriosis Research and Treatment (2 papers). Hong‐Yu Tseng collaborates with scholars based in Taiwan and United States. Hong‐Yu Tseng's co-authors include Hsin-Ling Hsu, Aushia Tanzih Al Haq, Yen‐An Chen, Li‐Mei Chen, Pei-Chun Shen, Yueh‐Shan Weng, Yi‐Chung Tung, Pai‐An Hwang, Chien‐Chia Wang and Limei Chen and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and Molecular Cancer.

In The Last Decade

Hong‐Yu Tseng

7 papers receiving 504 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

2019 333 citations Yueh‐Shan Weng, Hong‐Yu Tseng et al. Molecular Cancer profile →

Peers

Hong‐Yu Tseng

MB

ONCOL

CR

IMMUN

PRM

Aushia Tanzih Al Haq Taiwan

Hsin-Ling Hsu Taiwan

Dong-Min Shi China

Xiao‐Shun He China

Pei Wu China

Jia‐Peng Li China

Manoj Kumar Karuppusamy Rathinam United States

Tienian Zhu China

Aushia Tanzih Al Haq Taiwan

Hong‐Yu Tseng

255 ×0.9

MB

164 ×0.9

ONCOL

157 ×0.9

CR

159 ×1.0

IMMUN

58 ×0.9

PRM

Citations per year, relative to Hong‐Yu Tseng Hong‐Yu Tseng (= 1×) peers Aushia Tanzih Al Haq

Countries citing papers authored by Hong‐Yu Tseng

Since Specialization

Citations

This map shows the geographic impact of Hong‐Yu Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Yu Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Yu Tseng more than expected).

Fields of papers citing papers by Hong‐Yu Tseng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Yu Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Yu Tseng. The network helps show where Hong‐Yu Tseng may publish in the future.

Co-authorship network of co-authors of Hong‐Yu Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Yu Tseng. A scholar is included among the top collaborators of Hong‐Yu Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Yu Tseng. Hong‐Yu Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Haq, Aushia Tanzih Al, Christopher Jin, Jou‐Ho Shih, et al.. (2024). Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer. Theranostics. 14(5). 2167–2189. 16 indexed citations

2.

Haq, Aushia Tanzih Al, Hong‐Yu Tseng, Li‐Mei Chen, Chien‐Chia Wang, & Hsin-Ling Hsu. (2022). Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress. Cell Death and Disease. 13(1). 49–49. 33 indexed citations

3.

Chen, Li‐Mei, Hong‐Yu Tseng, Yen‐An Chen, et al.. (2020). Oligo-Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression. Cancers. 12(2). 421–421. 28 indexed citations

4.

Weng, Yueh‐Shan, Hong‐Yu Tseng, Yen‐An Chen, et al.. (2019). MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Molecular Cancer. 18(1). 42–42. 333 indexed citations breakdown →

5.

Chen, Limei, Po‐Yen Liu, Yen‐An Chen, et al.. (2017). Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression. Scientific Reports. 7(1). 11864–11864. 42 indexed citations

6.

Chio, Chung‐Ching, et al.. (2014). Involvement of TG‐interacting factor in microglial activation during experimental traumatic brain injury. Journal of Neurochemistry. 131(6). 816–824. 6 indexed citations

7.

Chen, Yi‐Ling, Yih‐Huei Uen, Chien‐Feng Li, et al.. (2012). The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma. Annals of Surgical Oncology. 20(12). 4041–4054. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact